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Abstract: Prediction of both the likelihood of bacteraemia and of death within 30 days allows for prudent 
decisions to be made regarding the diagnostic workup and therapy of patients with suspected sepsis. In this 
paper, we combine two predictive models and perform machine learning to tune the new model’s ability 
to predict both bacteraemia and 30-day mortality. The model was then validated on three independent 
datasets. There was no difference in the discriminatory ability of the model compared to each of the 
predecessors. For bacteraemia prediction, the new model had an AUC = 0.71 for the training data, and 
AUC = 0.73, 0.74 and 0.79 for the validation data. For mortality prediction, the model had an AUC = 0.81 
for the training data and AUC = 0.76, 0.84 and 0.80 for the validation data. 
Keywords: Decision support and control; Identification and validation; Model formulation, experiment 
design; Bayesian methods; Machine Learning 
1. INTRODUCTION 
Sepsis is the body’s systemic response to severe infection. It is 
a major healthcare problem with high mortality, ranging from 
approximately 15% in less severe cases to over 60% in cases 
with multiple organ dysfunction (Angus et al., 2001; Martin, 
Mannino, Eaton, & Moss, 2003; J.-L. Vincent et al., 2006). 
The ability to predict mortality allows for expedited diagnosis 
and improved treatment for those patients most in need. Sepsis 
definitions also reflect this, with the current consensus 
definitions designed to grade severity according to risk of 
death; the clinical criteria were chosen based on their 
performance in predicting in-hospital mortality and/or ICU 
stay (Seymour et al., 2016; Singer et al., 2016). Attempts have 
been made to design algorithms and clinical scores for 
mortality prediction among patients with suspected sepsis, 
such as SOFA (J. L. Vincent et al., 1996) (now part of the 
sepsis definitions) and MEDS (Shapiro et al., 2003). 
The diagnostic workup of a patient may additionally be guided 
by the likelihood of a clinically significant positive blood 
culture (bacteraemia); knowing the pre-test probability of 
bacteraemia allows prudent decisions to be made on the use of 
rapid diagnostics. Algorithms and clinical scores have been 
developed to predict bacteraemia, but none of these are in 
routine clinical use (Eliakim-Raz, Bates, & Leibovici, 2015). 
We have previously developed two models, Sepsis-B (L. M. 
Ward, 2016) and Sepsis-M (originally: LA-Sepsis CPN) (L. 
Ward, Paul, & Andreassen, 2017), capable of predicting 
bacteraemia and 30-day mortality, respectively. Compared 
with traditional scores, these models have the advantage that 
they can handle missing data, and give an explicit 
representation of the probability. 
The aim of this paper is to combine the two models in an 
attempt to improve the predictions by allowing the model to 
learn from both bacteraemia and mortality.  
2. MATERIALS AND METHODS 
In this paper, we describe the formation of the SepsisFinder 
CPN (Causal Probabilistic Network), tuning by machine 
learning, and validation on external datasets.  
2.1  Predictive model 
Model Construction 
The Sepsis-B (L. M. Ward, 2016) and Sepsis-M (L. Ward et 
al., 2017) models were merged. Figure 1 shows the merged 
model, with both 30-day mortality and bacteraemia as output 
variables. The Sepsis-B model used neutrophil fraction (the 
ratio between neutrophil and leucocyte counts) as an input 
variable, while the Sepsis-M model used leukocyte count as an 
input variable.  
In the merged model, neutrophil fraction was kept instead of 
leukocyte count due to its superior predictive performance on 
the training data (for both 30-day mortality and bacteraemia). 
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1. INTRODUCTION 
Sepsis is the body’s systemic response to severe infection. It is 
a major healthcare problem with high mortality, ranging from 
approximately 15% in less severe cases to over 60% in cases 
with multiple organ dysfunction (Angus et al., 2001; Martin, 
Mannino, Eaton, & Moss, 2003; J.-L. Vincent et al., 2006). 
The ability to predict mortality allows for expedited diagnosis 
and improved treatment for those patients most in need. Sepsis 
definitions also reflect this, with the current consensus 
definitions designed to grade severity according to risk of 
death; the clinical criteria were chosen based on their 
performance in predicting in-hospital mortality and/or ICU 
stay (Seymour et al., 2016; Singer et al., 2016). Attempts have 
been made to design algorithms and clinical scores for 
mortality prediction among patients with suspected sepsis, 
such as SOFA (J. L. Vincent et al., 1996) (now part of the 
sepsis definitions) and MEDS (Shapiro et al., 2003). 
The diagnostic workup of a patient may additionally be guided 
by the likelihood of a clinically significant positive blood 
culture (bacteraemia); knowing the pre-test probability of 
bacteraemia allows prudent decisions to be made on the use of 
rapid diagnostics. Algorithms and clinical scores have been 
developed to predict bacteraemia, but none of these are in 
routine clinical use (Eliakim-Raz, Bates, & Leibovici, 2015). 
We have previously developed two models, Sepsis-B (L. M. 
Ward, 2016) and Sepsis-M (originally: LA-Sepsis CPN) (L. 
Ward, Paul, & Andreassen, 2017), capable of predicting 
bacteraemia and 30-day mortality, respectively. Compared 
with traditional scores, these models have the advantage that 
they can handle missing data, and give an explicit 
representation of the probability. 
The aim of this paper is to combine the two models in an 
attempt to improve the predictions by allowing the model to 
learn from both bacteraemia and mortality.  
2. MATERIALS AND METHODS 
In this paper, we describe the formation of the SepsisFinder 
CPN (Causal Probabilistic Network), tuning by machine 
learning, and validation on external datasets.  
2.1  Predictive model 
Model Construction 
The Sepsis-B (L. M. Ward, 2016) and Sepsis-M (L. Ward et 
al., 2017) models were merged. Figure 1 shows the merged 
model, with both 30-day mortality and bacteraemia as output 
variables. The Sepsis-B model used neutrophil fraction (the 
ratio between neutrophil and leucocyte counts) as an input 
variable, while the Sepsis-M model used leukocyte count as an 
input variable.  
In the merged model, neutrophil fraction was kept instead of 
leukocyte count due to its superior predictive performance on 
the training data (for both 30-day mortality and bacteraemia). 
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attempt to improve the predictions by allowing the model to 
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Model Construction 
The Sepsis-B (L. M. Ward, 2016) and Sepsis-M (L. Ward et 
al., 2017) models were merged. Figure 1 shows the merged 
model, with both 30-day mortality and bacteraemia as output 
variables. The Sepsis-B model used neutrophil fraction (the 
ratio between neutrophil and leucocyte counts) as an input 
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mortality prediction among patients with suspected sepsis, 
such as SOFA (J. L. Vincent t al., 1996) (now part of the
sepsis definitions) and MEDS (Shap ro et al., 2003). 
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apid diag ostics. Algorithms and clinical scores have been 
develop d to predict bacteraemia, but none of these are in
routine clinical use (Eliakim-Raz, B tes, & Leibovici, 2015). 
e have previously d veloped two models, Sepsis-B (L. M.
Ward, 2016) and Sepsis-M (originally: LA-Sepsis CPN) (L. 
Ward, Paul, & ndreassen, 2017), capable of predicting 
bacteraemia  30-day mortality, respect ly. Com ared
with traditional scores, these models have the advantage that 
they can handle missing data, and give an explicit
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The aim of this paper is to combine the two models in an 
attempt to improve the predictions by allowing the model to 
learn from both bacteraemia and mortality.  
2. MATERIALS AND METHODS
In th s paper, we describe the formation of the SepsisFinder 
CPN (Causal Probabilistic Network), tuning by machine 
learning, and validation on external datasets.  
2.1  Predictive model 
Model Construction 
The Seps s-B (L. M. Ward, 2016) Sepsis-M (L. Ward e
al., 2017) models were merg d. Figur  1 shows the merged
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Figure 1: SepsisFinder CPN. The nodes where learning 
took place are coloured grey (stage 1) and black (stage 2). 
Training 
The model was trained using the Expectation-Maximisation 
(EM) method (Lauritzen, 1995). EM learning is a maximum 
likelihood method, and is offered as a tool for training CPNs 
in the commercial software Hugin (Hugin Expert A/S, 
Aalborg, Denmark). 
We used the same learning process as for the individual 
original models (L. Ward et al., 2017). First, the “mapping 
nodes”, “factor mapping nodes”, NSIRS, Sepsis, 
BackgroundMort, AgeRisk, AliveDay30 and Bacteraemia 
were learned (shaded grey in Figure 1). As a second step, 
“Infection” (shaded black in Figure 1) was learned to allow for 
cases where both NSIRS and Sepsis are present. NSIRS and 
Sepsis were not available in the annotated data. 
2.2  Datasets 
Training data: 2357 patients with suspected community-
acquired infection at Beilinson Hospital, Petah Tiqva, Israel 
from November 2014 to June 2016. Data were collected during 
routine clinical use of the clinical decision support system, 
TREAT (Andreassen et al., 2005; L Leibovici, Paul, & 
Andreassen, 2010; Leonard Leibovici, Paul, Nielsen, 
Tacconelli, & Andreassen, 2007; Paul et al., 2006). The 
following variables were used in training the model: presence 
of bacteraemia (yes/no), death within 30 days (yes/no), 
infectious diagnosis (yes/no), neutrophil fraction, lactate, C-
reactive protein, temperature, chills (yes/no), albumin, 
creatinine, calculated mean arterial pressure, heart rate, 
platelets, age, mental status (normal/confused/comatose). 
Three validation datasets were available, these will be referred 
to as HvH, SLB and TREAT04. Two of the datasets are from 
hospitals in Denmark (HvH and SLB), and one from the same 
hospital from which training data were gathered (TREAT04). 
HvH: 263 patients with suspected sepsis at Hvidovre Hospital, 
Hvidovre, Denmark; November 2011 – April 2012 (Arboe, 
Laub, Kronborg, & Knudsen, 2014). 
SLB: 199 patients with suspected sepsis at Lillebælt Hospital, 
Vejle, Denmark; July – August 2012 (L. M. Ward et al., 2013). 
TREAT04: From patients included in an interventional study 
of TREAT from May to November 2004 (Paul et al., 2006), 
the 1354 patients with community acquired infections were 
selected. 
2.3  Outcomes 
Outcomes were clinically significant bacteraemia, and 30-day 
mortality. Clinically significant bacteraemia is defined as 
blood culture positive for a clinically relevant pathogen. 
Aerococcus spp., Bacillus spp. (not B. anthracis), coagulase-
negative staphylococci, Corynebacterium spp., Micrococcus 
spp., Proprionibacterium acnes, and viridans streptococci 
were considered contaminants. 
To calculate the 30-day mortality, only the final episode was 
included for patients who were included multiple times within 
30 days. 
2.4  Statistical Analysis 
Differences between continuous variables were assessed using 
the independent samples Mann-Whitney U Test and 
categorical variables were assessed using the Pearson Chi-
squared statistic. EM learning was performed using Hugin 
(Version 8.5 (x64), Hugin Expert A/S), commercially 
available software for constructing and analysing CPNs. 
Discriminatory ability was assessed by the area under the 
receiver-operating characteristic (ROC) curve. Calibration 
assessed using the Hosmer-Lemeshow chi-squared statistic. 
Statistical analyses carried out in Matlab R2016a (The 
MathWorks, Inc). 
3. RESULTS 
The structure of the SepsisFinder CPN is shown in Figure 1. 
Table 1 presents descriptive statistics for the model input 
variables included in the training data. Table 2 presents the 
discriminatory performance of the individual variables 
included in the model and their ability to predict bacteraemia 
and mortality. This table presents the general performance 
profile of the variables in the univariate case. However, this is 
not fully representative of the performance as part of the 
model; for example, for some of the variables, both very high 
and very low values are considered pathological 
(fever/hypothermia, high/low platelet count). Despite this, we 
can see that some variables are better predictors of bacteraemia 
(e.g. neutrophil fraction or temperature) and others are better 
predictors of mortality (e.g. mean arterial pressure (MAP) or 
age). 
Following the learning process, we first tested the performance 
of the model on the training data itself. The Area under the 
ROC curve (AUC) was 0.81 (95% CI 0.79 – 0.84) for the 
model’s prediction of death within 30 days and 0.71 (95% CI 
0.67 – 0.75) for the model’s prediction of bacteraemia (Figure 
2, A and B).
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Table 1: Descriptive statistics for variables in the training data 
Variable All 
Median (IQR)/n (%) 
Bacteraemia 
Median (IQR)/n (%) 
Alive Day 30 
Median (IQR)/n (%) 
  yes no p* no yes p* 
Neutrophil 
fraction 
0.82 (0.74-0.88) 0.87 (0.81-0.92) 0.81 (0.73-0.87) <0.001 0.84 (0.78-0.90) 0.81 (0.73-0.87) <0.001 
Lactate 2.0 (1.4-2.8) 2.6 (1.9-3.8) 2.0 (1.4-2.7) <0.001 2.3 (1.8-3.4) 2.0 (1.4-2.7) <0.001 
CRP 76.7 (30.4-158.5) 119.5 (70.9-214.2) 72.6 (28.5-151.6) <0.001 105.9 (43.6-191.3) 74.3 (28.8-153.3) <0.001 
Temperature 37.8 (37.0-38.6) 38.3 (37.5-39.1) 37.7 (37.0-38.5) <0.001 37.6 (36.8-38.4) 37.8 (37.0-38.6) 0.002 
Chills 283 (14.6%) 34 (23.3%) 249 (13.9%) 0.008 16 (7.2%) 267 (15.6%) 0.001 
Albumin 37 (32-41) 34 (30-48) 37 (33-41) <0.001 32 (27-36) 37 (33-41) <0.001 
Creatinine 1.04 (0.79-1.48) 1.26 (0.89-1.76) 1.03 (0.77-1.45) <0.001 1.42 (0.90-2.35) 1.01 (0.77-1.41) <0.001 
MAP 80 (70-90) 78 (65-86) 80 (70-90) 0.001 72 (62-82) 81 (71-91) <0.001 
Heart rate 95 (83-110) 100 (88-113) 95 (83-110) 0.005 100 (86-116) 95 (83-110) 0.001 
Platelets 220 (162-301) 195 (149-292) 220 (162-301) 0.026 225 (153-346) 219 (162-294) 0.217 
Age 76 (64-85) 77 (66-84) 76 (64-85) 0.504 84 (75-89) 75 (63-84) <0.001 
Mental status 
  Normal 
  Confused 






















* Independent-samples Mann-Whitney U Test, distributions are not the same where p<0.05 
Table 2: Discriminatory performance of individual 
variables included in the model 
Variable Recorded 
(%) 






98.3% 0.67 (0.63-0.71) * 0.60 (0.56-0.63) * 
Lactate↑ 61.6% 0.65 (0.59-0.70) * 0.61 (0.57-0.66) * 
CRP↑ 77.2% 0.64 (0.59-0.68) * 0.58 (0.54-0.62) * 
Temperature↑ 99.2% 0.64 (0.59-0.68) * 0.44 (0.40-0.48) 
Albumin↓ 74.5% 0.62 (0.57-0.66) * 0.74 (0.70-0.77) * 
Creatinine↑ 97.5% 0.61 (0.56-0.65) * 0.65 (0.61-0.69) * 
MAP↓ 98.3% 0.58 (0.53-0.62) * 0.67 (0.63-0.70) * 
Heart rate↑ 98.2% 0.56 (0.52-0.61) * 0.56 (0.53-0.60) * 
Platelets↓ 98.3% 0.55 (0.51-0.60) * 0.48 (0.44-0.52) 
Age↑ 99.6% 0.52 (0.47-0.56) 0.68 (0.65-0.71) * 
↑: higher value predicts positive outcome (e.g. bacteraemia) 
↓: lower value predicts positive outcome (e.g. bacteraemia) 
*: significant predictor, p<0.05 (univariate analysis) 
In the calibration curves (Figure 2, C and D), cases are split 
into deciles based on the predicted probability, and observed 
and predicted rates of the outcome are plotted against each 
other. A perfectly calibrated model would plot as a y=x line. 
The Hosmer-Lemeshow statistic was 13.3 (8 degrees of 
freedom, p = 0.10) for the mortality predictions and 3.6 (8 d.f., 
p = 0.89) for the bacteraemia predictions, which suggests that 
the model is well calibrated for both sets of model predictions. 
Overall, the model predicted 7.5% bacteraemia; the actual 
bacteraemia rate was 7.6%. The model slightly overpredicted 
30-day mortality, with 13.6% predicted compared with 11.9% 
present in the dataset. 
The model performed well on all three validation datasets in 
terms of its predictive ability for both 30-day mortality and 
bacteraemia (Figure 3, A and B). There were no significant 
differences between the AUC for the training set and any of 
the validation sets. 
In addition, we compared the performance of the mortality 
predictions with those of the Sepsis-M CPN, and the 
bacteraemia predictions with those of the Sepsis-B CPN, 
performance statistics are given in Table 3. There were no 
significant differences for any of these comparisions.  
Table 3: Predictive performance of the SepsisFinder CPN 
vs. the Sepsis-B and Sepsis-M CPNs 
Dataset Bacteraemia Prediction 
Sepsis-B SF 
Training 0.72 (0.68-0.76) 0.71 (0.67-0.75) 
HvH 0.72 (0.62-0.82) 0.73 (0.69-0.78) 
SLB 0.80 (0.70-0.90) 0.79 (0.64-0.94) 
TREAT04 0.76 (0.72-0.81) 0.74 (0.69-0.78) 
Dataset Mortality Prediction 
Sepsis-M SF 
Training 0.81 (0.78-0.83) 0.81 (0.79-0.84) 
HvH 0.77 (0.67-0.88) 0.84 (0.77-0.90) 
SLB 0.83 (0.73-0.92) 0.80 (0.68-0.93) 
TREAT04 0.76 (0.72-0.80) 0.76 (0.72-0.80) 
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Lactate 2.0 (1.4-2.8) 2.6 (1.9-3.8) 2.0 (1.4-2.7) <0.001 2.3 (1.8-3.4) 2.0 (1.4-2.7) <0.001 
CRP 76.7 (30.4-158.5) 119.5 (70.9-214.2) 72.6 (28.5-151.6) <0.001 105.9 (43.6-191.3) 74.3 (28.8-153.3) <0.001 
Temperature 37.8 (37.0-38.6) 38.3 (37.5-39.1) 37.7 (37.0-38.5) <0.001 37.6 (36.8-38.4) 37.8 (37.0-38.6) 0.002 
Chills 283 (14.6%) 34 (23.3%) 249 (13.9%) 0.008 16 (7.2%) 267 (15.6%) 0.001 
Albumin 37 (32-41) 34 (30-48) 37 (33-41) <0.001 32 (27-36) 37 (33-41) <0.001 
Creatinine 1.04 (0.79-1.48) 1.26 (0.89-1.76) 1.03 (0.77-1.45) <0.001 1.42 (0.90-2.35) 1.01 (0.77-1.41) <0.001 
MAP 80 (70-90) 78 (65-86) 80 (70-90) 0.001 72 (62-82) 81 (71-91) <0.001 
Heart rate 95 (83-110) 100 (88-113) 95 (83-110) 0.005 100 (86-116) 95 (83-110) 0.001 
Platelets 220 (162-301) 195 (149-292) 220 (162-301) 0.026 225 (153-346) 219 (162-294) 0.217 
Age 76 (64-85) 77 (66-84) 76 (64-85) 0.504 84 (75-89) 75 (63-84) <0.001 
Mental status 
  Normal 
  Confused 






















* Independent-samples Mann-Whitney U Test, distributions are not the same where p<0.05 
Table 2: Discriminatory performance of individual 
variables included in the model 
Variable Recorded 
(%) 






98.3% 0.67 (0.63-0.71) * 0.60 (0.56-0.63) * 
Lactate↑ 61.6% 0.65 (0.59-0.70) * 0.61 (0.57-0.66) * 
CRP↑ 77.2% 0.64 (0.59-0.68) * 0.58 (0.54-0.62) * 
Temperature↑ 99.2% 0.64 (0.59-0.68) * 0.44 (0.40-0.48) 
Albumin↓ 74.5% 0.62 (0.57-0.66) * 0.74 (0.70-0.77) * 
Creatinine↑ 97.5% 0.61 (0.56-0.65) * 0.65 (0.61-0.69) * 
MAP↓ 98.3% 0.58 (0.53-0.62) * 0.67 (0.63-0.70) * 
Heart rate↑ 98.2% 0.56 (0.52-0.61) * 0.56 (0.53-0.60) * 
Platelets↓ 98.3% 0.55 (0.51-0.60) * 0.48 (0.44-0.52) 
Age↑ 99.6% 0.52 (0.47-0.56) 0.68 (0.65-0.71) * 
↑: higher value predicts positive outcome (e.g. bacteraemia) 
↓: lower value predicts positive outcome (e.g. bacteraemia) 
*: significant predictor, p<0.05 (univariate analysis) 
In the calibration curves (Figure 2, C and D), cases are split 
into deciles based on the predicted probability, and observed 
and predicted rates of the outcome are plotted against each 
other. A perfectly calibrated model would plot as a y=x line. 
The Hosmer-Lemeshow statistic was 13.3 (8 degrees of 
freedom, p = 0.10) for the mortality predictions and 3.6 (8 d.f., 
p = 0.89) for the bacteraemia predictions, which suggests that 
the model is well calibrated for both sets of model predictions. 
Overall, the model predicted 7.5% bacteraemia; the actual 
bacteraemia rate was 7.6%. The model slightly overpredicted 
30-day mortality, with 13.6% predicted compared with 11.9% 
present in the dataset. 
The model performed well on all three validation datasets in 
terms of its predictive ability for both 30-day mortality and 
bacteraemia (Figure 3, A and B). There were no significant 
differences between the AUC for the training set and any of 
the validation sets. 
In addition, we compared the performance of the mortality 
predictions with those of the Sepsis-M CPN, and the 
bacteraemia predictions with those of the Sepsis-B CPN, 
performance statistics are given in Table 3. There were no 
significant differences for any of these comparisions.  
Table 3: Predictive performance of the SepsisFinder CPN 
vs. the Sepsis-B and Sepsis-M CPNs 
Dataset Bacteraemia Prediction 
Sepsis-B SF 
Training 0.72 (0.68-0.76) 0.71 (0.67-0.75) 
HvH 0.72 (0.62-0.82) 0.73 (0.69-0.78) 
SLB 0.80 (0.70-0.90) 0.79 (0.64-0.94) 
TREAT04 0.76 (0.72-0.81) 0.74 (0.69-0.78) 
Dataset Mortality Prediction 
Sepsis-M SF 
Training 0.81 (0.78-0.83) 0.81 (0.79-0.84) 
HvH 0.77 (0.67-0.88) 0.84 (0.77-0.90) 
SLB 0.83 (0.73-0.92) 0.80 (0.68-0.93) 
TREAT04 0.76 (0.72-0.80) 0.76 (0.72-0.80) 
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Figure 2: Performance of the model on the training data. A: ROC curve for model predicted probability of death within 
30 days. B: ROC curve for model predicted probability of bacteraemia. C: Calibration curves for observed vs. model 
predicted probability of death within 30 days. D: Calibration curves for observed vs. model predicted probability of 
bacteraemia. HL = Hosmer-Lemeshow statistic, p>0.05 indicates no significant deviation. 
According to the Hosmer-Lemeshow statistic, the model 
predicted probabilities of 30-day mortality and bacteraemia 
were well calibrated (p>0.24 for all) for both the HvH and SLB 
datasets (Figure 3, C and D). This is also seen in the overall 
predictions matching the observations. For the HvH dataset, 
the model predicted 6.2% bacteraemia and 10.9% mortality 
where the observed rates were 6.8% and 8.8%. For the SLB 
dataset, the model predicted 5.5% bacteraemia and 6.3% 
mortality; the observed rates were 6.0% and 6.5%. However, 
for the TREAT04 dataset, the deviations were significant (p = 
3x10-5). with under-prediction of mortality: overall predicted 
mortality was 9.1% vs. an observed mortality of 11.5%. 
Bacteraemia was also under-predicted with a predicted 
probability of 7.4% vs. an observed probability of 9.3%. 
4. DISCUSSION 
We combined two CPN models and trained them to provide 
predictions of the probability of bacteraemia and of death 
within 30 days. Models performed well on the training data 
and external validation both in terms of discriminatory 
performance and generally in terms of calibration. The 
combined model performed better than all individual finding, 
both for mortality and bacteraemia predictions. The model 
performed as well as the two original models.  
The model was trained using data from a hospital in Israel, and 
validated using datasets from two hospitals in Denmark, and 
an additional dataset from the hospital at which training data 
were collected. The four datasets in this study were collected 
over different time periods (ranging from 2004 to 2016), and 
had different rates and types of missing data (data not shown). 
The model appears to be robust, with no evidence of 
overfitting; no degradation in performance relative to the 
training dataset was observed for any of the validation 
datasets. One limitation of this study was the small size of the 
SLB and HvH datasets. 
At the time that the TREAT04 data were collected, fewer lab 
tests were run per patient. This dataset had fewer data per 
patient overall, and in particular fewer of the ‘good’ data i.e. 
CRP for bacteraemia prediction, and albumin for prediction of 
death within 30 days. 
The mortality predictions for the TREAT04 dataset appeared 
to have a systematic offset in mortality prediction. The 
gradient of the calibration curve was 0.98, and the offset was 
+0.03. This could potentially be explained as a higher 
background mortality in this cohort not accounted for by the 
model.
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Figure 3: Performance of the model on the three validation datasets. A: ROC curve for model predicted probability of 
death within 30 days. B: ROC curve for model predicted probability of bacteraemia. C: Calibration curves for observed 
vs. model predicted probability of death within 30 days. D: Calibration curves for observed vs. model predicted 
probability of bacteraemia. HL = Hosmer-Lemeshow statistic, p>0.05 indicates no significant deviation. 
There are a number of confounding factors for bacteraemia, 
which can be either laboratory- or patient-specific. Typically, 
we expect higher likelihood of bacteraemia in more severe 
infections, but it is also dependent on the type of infection (i.e. 
whether there is an easy path to the bloodstream in e.g. 
endocarditis) and also if blood was drawn before antibiotics 
were administered. Differences between microbiology labs in 
terms of their blood culture procedures may also affect the 
probability of detecting microbes in the blood cultures.  
CPN models possess some advantages over other forms of 
predictive model, notably their inherent ability to handle 
missing data. This ability is particularly useful in the medical 
domain, where both the quality and amount of data recorded 
for a given patient can vary significantly between and even 
within healthcare centres.  
The predictive performance of the model described in this 
study are in line with other models described in the literature. 
The current sepsis definition uses the SOFA score, in 
particular for ICU patients, while also recommending the use 
of qSOFA (or “quick SOFA”) for patients outside the ICU 
(Singer et al., 2016). The study describing the clinical criteria 
for sepsis shows good performance for both these scores in 
predicting in-hospital mortality in a large validation dataset, 
with AUC  = 0.74 (all) and 0.79 (non-ICU) for SOFA and for 
0.66 (all) and 0.81 (non-ICU) for qSOFA (Seymour et al., 
2016). Despite these results, there has been significant debate 
surrounding the use of qSOFA and SOFA for sepsis screening, 
with mixed results reported in the literature (Askim et al., 
2017; Carneiro, Póvoa, & Gomes, 2017; Franchini & Duca, 
2016; Freund et al., 2017; Hwang et al., 2017; Kim et al., 
2017). A recent review described a number of efforts made to 
develop models to predict bacteraemia, none of which were in 
routine clinical use (Eliakim-Raz et al., 2015). AUCs for the 
predictive models ranged from 0.62-0.79, similar to what we 
found in this study. 
One possible application of this model is as part of a decision 
support system for the microbiology laboratory. Expensive, 
rapid diagnostics can be suggested for patients with a high 
likelihood of returning an actionable positive result (high 
probability of bacteraemia) and/or greater need for rapid 
appropriate therapy (high probability of mortality). 
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predictive model, notably their inherent ability to handle 
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domain, where both the quality and amount of data recorded 
for a given patient can vary significantly between and even 
within healthcare centres.  
The predictive performance of the model described in this 
study are in line with other models described in the literature. 
The current sepsis definition uses the SOFA score, in 
particular for ICU patients, while also recommending the use 
of qSOFA (or “quick SOFA”) for patients outside the ICU 
(Singer et al., 2016). The study describing the clinical criteria 
for sepsis shows good performance for both these scores in 
predicting in-hospital mortality in a large validation dataset, 
with AUC  = 0.74 (all) and 0.79 (non-ICU) for SOFA and for 
0.66 (all) and 0.81 (non-ICU) for qSOFA (Seymour et al., 
2016). Despite these results, there has been significant debate 
surrounding the use of qSOFA and SOFA for sepsis screening, 
with mixed results reported in the literature (Askim et al., 
2017; Carneiro, Póvoa, & Gomes, 2017; Franchini & Duca, 
2016; Freund et al., 2017; Hwang et al., 2017; Kim et al., 
2017). A recent review described a number of efforts made to 
develop models to predict bacteraemia, none of which were in 
routine clinical use (Eliakim-Raz et al., 2015). AUCs for the 
predictive models ranged from 0.62-0.79, similar to what we 
found in this study. 
One possible application of this model is as part of a decision 
support system for the microbiology laboratory. Expensive, 
rapid diagnostics can be suggested for patients with a high 
likelihood of returning an actionable positive result (high 
probability of bacteraemia) and/or greater need for rapid 
appropriate therapy (high probability of mortality). 
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